Annual report
7751.TEDINET S100XTLJ
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardUS GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.62T | 2025-01-01 → 2025-12-31 | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.51T | 2024-01-01 → 2024-12-31 | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.18T | 2023-01-01 → 2023-12-31v | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.03T | 2022-01-01 → 2022-12-31v | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥3.51T | 2021-01-01 → 2021-12-31d | Cons. | Revenues US GAAP (5-year summary) |
| Profit before tax | ¥482.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥301.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥390.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥352.4bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥302.7bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Net income (owners) | ¥332.1bn | 2025-01-01 → 2025-12-31 | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥160.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥264.5bn | 2023-01-01 → 2023-12-31v | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥244.0bn | 2022-01-01 → 2022-12-31v | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥214.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Total assets | ¥6.14T | at 2025-12-31 | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.77T | at 2024-12-31 | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.42T | at 2023-12-31v | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.10T | at 2022-12-31v | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥4.75T | at 2021-12-31d | Cons. | Total assets US GAAP (5-year summary) |
| Equity (owners) | ¥3.49T | at 2025-12-31 | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.38T | at 2024-12-31 | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.35T | at 2023-12-31v | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.11T | at 2022-12-31v | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥2.87T | at 2021-12-31d | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Cash & equivalents | ¥586.0bn | at 2025-12-31 | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥501.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥401.3bn | at 2023-12-31v | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥362.1bn | at 2022-12-31v | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥401.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Operating cash flow | ¥475.9bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥606.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥451.2bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥262.6bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥451.0bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Investing cash flow | −¥237.4bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥297.3bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥275.4bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥180.8bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥207.3bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Financing cash flow | −¥179.2bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥226.0bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥156.7bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥146.8bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥267.4bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| EPS (basic) | ¥367.48 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥165.53 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥264.2 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥236.71 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥205.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥367.25 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥165.44 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥264.08 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥236.63 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥205.29 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| Net assets per share | ¥3,974.81 | at 2025-12-31 | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,581.36 | at 2024-12-31 | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,394.92 | at 2023-12-31v | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,065.97 | at 2022-12-31v | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥2,748.36 | at 2021-12-31d | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Equity ratio | 56.9% | at 2025-12-31 | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 58.6% | at 2024-12-31 | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 61.9% | at 2023-12-31v | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 61.1% | at 2022-12-31v | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 60.5% | at 2021-12-31d | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| ROE | 9.7% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 4.8% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 8.2% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 8.1% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 7.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity US GAAP (5-year summary) |
| Employees | 165,547 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 170,340 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 169,151 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 180,775 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 184,034 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥1.84T | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥1.89T | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥1.67T | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.51T | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥178.2bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥220.2bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥324.3bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥465.5bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥511.6bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥214.3bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥248.0bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥312.0bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥524.1bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥262.1bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥469.1bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥476.8bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥193.6bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥228.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.98T | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.03T | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥2.94T | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.91T | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.82T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.45T | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.31T | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.53T | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.72T | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.59T | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥1.34T | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.37T | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥20.5bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥44.7bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥289.97 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥485.14 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥476.12 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥187.84 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥218.02 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥289.79 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥484.9 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥475.92 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥187.78 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥217.96 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥160 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥155 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥140 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥120 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,741.54 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,816.9 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,610.54 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,319.84 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,307.1 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 51.3% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.7% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.0% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.5% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.1% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 28.4% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 32.5% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,333,763,464 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 22,921 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 23,457 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 23,931 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 24,717 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 25,377 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Imaging Business Unitreportable segment | employees | at 2025-12-31 | 26367 pure |
| Industry Business Unitreportable segment | employees | at 2025-12-31 | 7757 pure |
| Medical Business Unitreportable segment | employees | at 2025-12-31 | 13347 pure |
| Printing Business Unitreportable segment | employees | at 2025-12-31 | 105938 pure |
| Imaging Business Unitreportable segment | employees | at 2025-12-31 | 3899 pure |
| Industry Business Unitreportable segment | employees | at 2025-12-31 | 2558 pure |
| Medical Business Unitreportable segment | employees | at 2025-12-31 | 604 pure |
| Printing Business Unitreportable segment | employees | at 2025-12-31 | 8873 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,502
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)森重秀一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中村 進 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高木秀明 | |
| Cpa4 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)中井雅佳 | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)のれんの減損テスト ― メディカル報告単位 | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)連結財務諸表注記1及び8 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)森重秀一 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)中村 進 | |
| Cpa3 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)高木秀明 | |
| Cpa4 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)中井雅佳 | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)子会社株式の評価 ― キヤノンメディカルシステムズ株式会社の株式 | |
| Reference kam non consolidated | FilingDateInstant_Row1Member | Original text (Japanese)財務諸表注記（重要な会計上の見積り）及び（有価証券関係） | |
| Description including reason kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Auditors response kam non consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Revenues US GAAP (5-year summary) | Prior4YearDuration | 3513357000000 | JPY |
| Revenues US GAAP (5-year summary) | Prior3YearDuration | 4031414000000 | JPY |
| Revenues US GAAP (5-year summary) | Prior2YearDuration | 4180972000000 | JPY |
| Revenues US GAAP (5-year summary) | Prior1YearDuration | 4509821000000 | JPY |
| Revenues US GAAP (5-year summary) | CurrentYearDuration | 4624727000000 | JPY |
| Profit loss before tax US GAAP (5-year summary) | Prior4YearDuration | 302706000000 | JPY |
| Profit loss before tax US GAAP (5-year summary) | Prior3YearDuration | 352440000000 | JPY |
| Profit loss before tax US GAAP (5-year summary) | Prior2YearDuration | 390767000000 | JPY |
| Profit loss before tax US GAAP (5-year summary) | Prior1YearDuration | 301161000000 | JPY |
| Profit loss before tax US GAAP (5-year summary) | CurrentYearDuration | 482059000000 | JPY |
| Net income loss attributable to owners of parent US GAAP (5-year summary) | Prior4YearDuration | 214718000000 | JPY |
| Net income loss attributable to owners of parent US GAAP (5-year summary) | Prior3YearDuration | 243961000000 | JPY |
| Net income loss attributable to owners of parent US GAAP (5-year summary) | Prior2YearDuration | 264513000000 | JPY |
| Net income loss attributable to owners of parent US GAAP (5-year summary) | Prior1YearDuration | 160025000000 | JPY |
| Net income loss attributable to owners of parent US GAAP (5-year summary) | CurrentYearDuration | 332053000000 | JPY |
| Comprehensive income US GAAP (5-year summary) | Prior4YearDuration | 406815000000 | JPY |
| Comprehensive income US GAAP (5-year summary) | Prior3YearDuration | 476959000000 | JPY |
| Comprehensive income US GAAP (5-year summary) | Prior2YearDuration | 495000000000 | JPY |
| Comprehensive income US GAAP (5-year summary) | Prior1YearDuration | 393160000000 | JPY |
| Comprehensive income US GAAP (5-year summary) | CurrentYearDuration | 597419000000 | JPY |
| Equity attributable to owners of parent US GAAP (5-year summary) | Prior4YearInstant | 2873773000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |